Current Status of COVID-19 Pseudovirus Testing

See all Products

COVID-19 Pseudovirus Whole Genome Quality Control Products Details

Our accurate and stable COVID-19 pseudovirus genome-wide quality control products include 2019-nCov virus genome-wide pseudoviruses and can be adapted to the quality control needs of all approved nucleic acid detection kits on the market.

Production Process

Our COVID-19 pseudovirus whole genome quality control product accurately quantifies the copy number of viral genes after extraction by ddPCR, and after lysis, we can obtain a quality control that is accurately quantified as weakly positive.

Product Highlights

• The product form is a pseudovirus, which highly simulates real clinical samples.
• Covers the whole genome sequence of the virus and is suitable for the approved nucleic acid test kits in the market.
• The product can be used for quality control of the entire testing process from the sampling step.
• Contains internal reference gene RNase P for internal reference quality control.
• The product form of lyophilized beads has better stability, can be transported at room temperature and can be stored stably at 2-8°C for at least 24 months.
• Depending on the detection limit of the kit, weakly positive QCs with copy number concentrations in the range of 1.5~3 times the detection limit can be formulated.
• Accurate quantification of viral genome copy number by digital PCR after sample extraction.

Applications

• Our COVID-19 pseudovirus genome-wide quality control products can be involved in the testing process of each batch of clinical samples to monitor and control the accuracy of laboratory assays.
• Our COVID-19 pseudovirus genome-wide quality control products can assist the performance evaluation of new crown testing capabilities at the clinical testing center or at each higher level of the organization.

Product Categories

• COVID-19 pseudovirus positive control